Słotwiński R - Search Results

1

Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.

Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW. Lech G, et al. Among authors: slotwinski r. World J Gastroenterol. 2016 Feb 7;22(5):1745-55. doi: 10.3748/wjg.v22.i5.1745. World J Gastroenterol. 2016. PMID: 26855534 Free PMC article. Review.

2

Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome.

Lech G, Korcz W, Kowalczyk E, Słotwiński R, Słodkowski M. Lech G, et al. Among authors: slotwinski r. Scand J Gastroenterol. 2017 Nov;52(11):1194-1202. doi: 10.1080/00365521.2017.1356932. Epub 2017 Jul 24. Scand J Gastroenterol. 2017. PMID: 28737049 Review.

3

MicroRNAs in pancreatic cancer diagnosis and therapy.

Słotwiński R, Lech G, Słotwińska SM. Słotwiński R, et al. Cent Eur J Immunol. 2018;43(3):314-324. doi: 10.5114/ceji.2018.80051. Epub 2018 Oct 30. Cent Eur J Immunol. 2018. PMID: 30588176 Free PMC article. Review.

4

Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets.

Słotwiński R, Lech G, Słotwińska SM. Słotwiński R, et al. Cent Eur J Immunol. 2021;46(2):258-263. doi: 10.5114/ceji.2021.107027. Epub 2021 Jun 16. Cent Eur J Immunol. 2021. PMID: 34764796 Free PMC article. Review.

5

The role of tumor markers and biomarkers in colorectal cancer.

Lech G, Slotwinski R, Krasnodebski IW. Lech G, et al. Among authors: slotwinski r. Neoplasma. 2014;61(1):1-8. Neoplasma. 2014. PMID: 24195503 Review.

6

The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery.

Slotwiński R, Olszewski WL, Chaber A, Slodkowski M, Zaleska M, Krasnodebski IW. Slotwiński R, et al. J Clin Immunol. 2002 Sep;22(5):289-96. doi: 10.1023/a:1020022006043. J Clin Immunol. 2002. PMID: 12405162

7

Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression.

Słotwiński R, Dąbrowska A, Lech G, Słodkowski M, Słotwińska SM. Słotwiński R, et al. Cent Eur J Immunol. 2014;39(4):498-507. doi: 10.5114/ceji.2014.47736. Epub 2014 Dec 15. Cent Eur J Immunol. 2014. PMID: 26155170 Free PMC article.

8

Apoptosis in lymphocytes of pancreatic cancer patients: influence of preoperative enteral immunonutrition and extensive surgery.

Słotwiński R, Olszewski W, Słodkowski M, Lech G, Zaleska M, Kędziora S, Włuka A, Domaszewska A, Słotwińska S, Krasnodębski W, Wójcik Z. Słotwiński R, et al. Arch Immunol Ther Exp (Warsz). 2011 Oct;59(5):385-97. doi: 10.1007/s00005-011-0140-3. Epub 2011 Aug 5. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21818634 Free article.

9

Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?

Slotwinski R, Olszewski WL, Slotkowski M, Lech G, Zaleska M, Slotwinska SM, Krasnodebski WI. Slotwinski R, et al. JOP. 2007 Nov 9;8(6):759-69. JOP. 2007. PMID: 17993728 Clinical Trial.

10

[Alteration of serum interleukin-1 receptor antagonist and interleukin-6 levels after surgical injury].

Słotwiński R, Lech G, Gomuła J, Zaleska M, Krasnodebski IW. Słotwiński R, et al. Pol Merkur Lekarski. 2003 Sep;15(87):231-4. Pol Merkur Lekarski. 2003. PMID: 14679846 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page